EE200100193A - 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises - Google Patents

3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises

Info

Publication number
EE200100193A
EE200100193A EEP200100193A EEP200100193A EE200100193A EE 200100193 A EE200100193 A EE 200100193A EE P200100193 A EEP200100193 A EE P200100193A EE P200100193 A EEP200100193 A EE P200100193A EE 200100193 A EE200100193 A EE 200100193A
Authority
EE
Estonia
Prior art keywords
indan
imidazol
ylmethyl
intraspinal
intra
Prior art date
Application number
EEP200100193A
Other languages
English (en)
Estonian (et)
Inventor
Haapalinna Antti
Lehtim�ki Jyrki
Leino Tiina
Viitamaa Timo
Virtanen Raimo
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of EE200100193A publication Critical patent/EE200100193A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EEP200100193A 1998-09-28 1999-09-27 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises EE200100193A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10198698P 1998-09-28 1998-09-28
PCT/FI1999/000793 WO2000018400A1 (en) 1998-09-28 1999-09-27 Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration

Publications (1)

Publication Number Publication Date
EE200100193A true EE200100193A (et) 2002-08-15

Family

ID=22287519

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100193A EE200100193A (et) 1998-09-28 1999-09-27 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises

Country Status (24)

Country Link
US (1) US6495584B1 (xx)
EP (1) EP1117399B1 (xx)
JP (1) JP4647785B2 (xx)
KR (1) KR100646811B1 (xx)
CN (1) CN1320034A (xx)
AT (1) ATE288753T1 (xx)
AU (1) AU756104B2 (xx)
BG (1) BG105469A (xx)
CA (1) CA2345521C (xx)
CZ (1) CZ299918B6 (xx)
DE (1) DE69923698T2 (xx)
DK (1) DK1117399T3 (xx)
EA (1) EA003216B1 (xx)
EE (1) EE200100193A (xx)
ES (1) ES2237205T3 (xx)
HK (1) HK1039751A1 (xx)
HU (1) HU227634B1 (xx)
IL (2) IL141680A0 (xx)
NO (1) NO330436B1 (xx)
NZ (1) NZ510233A (xx)
PL (1) PL346908A1 (xx)
SK (1) SK3812001A3 (xx)
UA (1) UA61152C2 (xx)
WO (1) WO2000018400A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1196168A2 (en) * 1999-06-25 2002-04-17 Orion Corporation Method of admistering an imidazole derivative to obtain analgesia
FI20022159A0 (fi) 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US5801188A (en) * 1997-01-08 1998-09-01 Medtronic Inc. Clonidine therapy enhancement

Also Published As

Publication number Publication date
CZ299918B6 (cs) 2008-12-29
CA2345521C (en) 2009-05-05
DE69923698T2 (de) 2006-01-12
DK1117399T3 (da) 2005-03-29
DE69923698D1 (de) 2005-03-17
KR20010079860A (ko) 2001-08-22
AU5986099A (en) 2000-04-17
BG105469A (en) 2001-11-30
IL141680A0 (en) 2002-03-10
HU227634B1 (en) 2011-10-28
EA200100405A1 (ru) 2001-10-22
HUP0103864A2 (hu) 2002-05-29
HK1039751A1 (zh) 2002-05-10
EP1117399B1 (en) 2005-02-09
AU756104B2 (en) 2003-01-02
SK3812001A3 (en) 2002-02-05
NO20011545D0 (no) 2001-03-26
CN1320034A (zh) 2001-10-31
NO20011545L (no) 2001-03-26
EP1117399A1 (en) 2001-07-25
IL141680A (en) 2007-06-17
KR100646811B1 (ko) 2006-11-17
NO330436B1 (no) 2011-04-11
JP2002525324A (ja) 2002-08-13
NZ510233A (en) 2003-05-30
CZ2001933A3 (cs) 2001-08-15
CA2345521A1 (en) 2000-04-06
UA61152C2 (en) 2003-11-17
EA003216B1 (ru) 2003-02-27
PL346908A1 (en) 2002-03-11
US6495584B1 (en) 2002-12-17
JP4647785B2 (ja) 2011-03-09
HUP0103864A3 (en) 2002-08-28
WO2000018400A1 (en) 2000-04-06
ES2237205T3 (es) 2005-07-16
ATE288753T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
US7834053B2 (en) Medicinal compositions improving brain function and method for improving brain function
CY1111088T1 (el) Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση
EA200501496A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
DE60128258D1 (de) Indanylderivate zur Behandlung von Atemwegserkrankungen
TNSN04246A1 (fr) Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation
EE200300106A (et) Farmatseutiline kompositsioon kui süsteemne analgeetikum
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
NO20055655D0 (no) Anvendelse av azetidinkarboksamidderivater i terapi
ATE279192T1 (de) Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
WO1994016689A1 (en) Analgesic medicinal composition
HUP9901208A2 (hu) (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény
EE200100193A (et) 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
SE9900190D0 (sv) New compounds
PT1082116E (pt) Utilizacao de derivados de 4-piperidinometanol no tratamento de desordens do neurodesenvolvimento
MXPA04010658A (es) Tratamiento de dolor con ifenprodil.
Rorarius et al. The effect of diclofenac and ketoprofen on halothane MAC in rabbit
MXPA02007454A (es) Compuestos utiles para tratamiento o prevencion de una enfermedad mediada por el alfa-2b-adrenoceptor.
KR910007526A (ko) 인터류킨-1 생합성 억제제로의 3-치화된-2-옥신돌 유도체
WO2001000192A3 (en) Method of administering an imidazole derivative to obtain analgesia
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
RU2002121654A (ru) Способ обезболивания при операциях на конечностях